Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer?
Prostate cancer (PCa) is a highly prevalent malignancy and constitutes a major cause of cancer-related morbidity and mortality. It emerges through the acquisition of genetic and epigenetic alterations. Epigenetic modifications include DNA methylation, histone modifications and microRNA deregulation....
| Main Author: | |
|---|---|
| Other Authors: | , , |
| Format: | review |
| Language: | eng |
| Published: |
2020
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10362/94246 |
| Country: | Portugal |
| Oai: | oai:run.unl.pt:10362/94246 |